Trials / Completed
CompletedNCT05834270
Single Dose Versus Double Dose Tamsulosin in Management of Moderate and Severe LUTS Due to BPH
Single Dose Versus Double Dose Tamsulosin in Management of Moderate and Severe Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Menoufia University · Academic / Other
- Sex
- Male
- Age
- 50 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Single dose versus double dose tamsulosin in Management of Moderate and severe lower urinary tract symptoms due to benign prostatic hyperplasia
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Single dose tamsulosin 0.4mg | Single dose tamsulosin 0.4mg |
| DRUG | Double dose tamsulosin 0.4mg | Double dose tamsulosin 0.4mg |
Timeline
- Start date
- 2022-05-01
- Primary completion
- 2022-12-01
- Completion
- 2022-12-01
- First posted
- 2023-04-28
- Last updated
- 2023-04-28
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT05834270. Inclusion in this directory is not an endorsement.